Sir,
Autologous serum has been used effectively to treat severe dry eye syndrome1 (DES) and persistent epithelial defects2 (PED). However, difficulty obtaining funding and delays in production often make it unfeasible for acute cases. The authors report on finger prick autologous blood (FAB)3 as an alternative treatment option.
Patients cleaned a finger with an alcohol steret. Next, they produced a drop of blood using a diabetic lancet and applied it to their lower fornix. They repeated this technique to apply FAB four times per day to each eye. A different finger was used for each eye to reduce any risk of cross-infection.
Case report
Patient 1: A 64-year-old diabetic man presented with a 1-mm2 neuropathic PED affecting the right eye (OD) and extensive punctate erosions affecting the left eye (OS). He had experienced DES symptoms for 1 year. He was commenced on intensive lubrication to both eyes for 12 days without improvement (Celluvisc and Hyloforte hourly by day and lacrilube by night). FAB was then commenced and by day 4 there was complete resolution of the PED (OD) and punctate erosions (OS) (Figure 1).
Patient 2: A 51-year-old woman with Sjőgrens presented with longstanding bilateral DES. She was on maximal medical therapy and had had bilateral punctal cautery. After 2 months on FAB her ocular comfort index (OCI)4 improved from 55/72 to 4/72 and her fluorescein staining improved bilaterally (Figure 2).
Patient 3: A 45-year-old man with Sjőgrens presented with persistent DES (OS) and reduced visual acuity. He was on hourly lubricants and had punctal plugs. Three days after commencing FAB his OCI remained unchanged but acuity improved from 6/9 to 6/5 OS and punctate staining improved from Oxford grade 4 to 3.
Comment
We conclude that FAB can effectively treat neuropathic PED and DES in primary Sjőgrens. Patients tolerated the treatment well without any complications. The effectiveness of FAB is probably by the action of the fresh growth factors5 found in plasma. Occasional FAB clot formation, reported in the lower fornix by one patient, would probably result in the sustained release of further growth factors.
References
Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004; 88: 647–652.
Poon AC, Geerling G, Dart JK, Fraenkel GE, Daniels JT . Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 2001; 85: 1188–1197.
Sharma A, Sharma BA, Moore J, Nolan M . Simple finger prick fresh blood technique for use on the ocular surface. Cont Lens Anterior Eye 2011; 34 (1): 49.
Johnson ME, Murphy PJ . Measurement of ocular surface irritation on a linear interval scale with the ocular comfort index. Invest Ophthalmol Vis Sci 2007; 48 (10): 4451–4458.
Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S . Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res 2000; 19 (1): 113–129.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Wawrzynski, J., Mukherjee, H., Moore, J. et al. Fingerprick autologous blood for dry eyes and persistent epithelial defects. Eye 30, 635–636 (2016). https://doi.org/10.1038/eye.2015.258
Published:
Issue Date:
DOI: https://doi.org/10.1038/eye.2015.258